Platform
Features
0 followers
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.
Industries
Headquarters
Stage
Employees
Links
Thomas Cavanagh
11 members
3 members
2 members
Achillestx
2 followers
Tessera Therapeutics
Vaxcyte
Vera Therapeutics
Autolus
1 follower
Day One Biopharmaceuticals
QurAlis
Aura Biosciences
MedRhythms
Outlier Ventures
5 followers
Incident.io
4 followers
Discover companies